






































Pediatric pain treatment and prevention for
hospitalized children
Stefan J. Friedrichsdorfa,b,c,*, Liesbet Goubertd
Abstract
Introduction: Prevention and treatment of pain in pediatric patients compared with adults is often not only inadequate but also less
often implemented the younger the children are. Children 0 to 17 years are a vulnerable population.
Objectives: To address the prevention and treatment of acute and chronic pain in children, including pain caused by needles, with
recommended analgesic starting doses.
Methods: This Clinical Update elaborates on the 2019 IASP Global Year Against Pain in the Vulnerable “Factsheet Pain in Children:
Management” and reviews best evidence and practice.
Results: Multimodal analgesia may include pharmacology (eg, basic analgesics, opioids, and adjuvant analgesia), regional
anesthesia, rehabilitation, psychological approaches, spirituality, and integrative modalities, which act synergistically for more
effective acute pediatric pain control with fewer side effects than any single analgesic or modality. For chronic pain, an
interdisciplinary rehabilitative approach, including physical therapy, psychological treatment, integrative mind–body techniques,
and normalizing life, has been shown most effective. For elective needle procedures, such as blood draws, intravenous access,
injections, or vaccination, overwhelming evidence nowmandates that a bundle of 4 modalities to eliminate or decrease pain should
be offered to every child every time: (1) topical anesthesia, eg, lidocaine 4% cream, (2) comfort positioning, eg, skin-to-skin contact
for infants, not restraining children, (3) sucrose or breastfeeding for infants, and (4) age-appropriate distraction. A deferral process
(Plan B) may include nitrous gas analgesia and sedation.
Conclusion: Failure to implement evidence-based pain prevention and treatment for children in medical facilities is now considered
inadmissible and poor standard of care.
Keywords: Pediatric pain, Pain treatment, Pain prevention, Multimodal analgesia, Topical anesthesia, Comfort positioning,
Sucrose, Breastfeeding, Distraction
1. Introduction
Data from children’s hospitals around the world reveal that pain in
pediatric patients from infancy to adolescence is common,
under-recognized and undertreated.6,48,144,148,162,170,179 Com-
pared with adult patients, pediatric patients with the same
diagnoses receive less analgesic doses, and the younger the
children are, the less likely it is that they receive adequate
analgesia in the medical setting.5,9,117,137
The pain experienced by children in a hospital, medical facility, or
doctor’s office canbedisease- and/or treatment-related andmaybe
based on one, several, or all of the following pathophysiologies:
(1) Acute somatic pain (eg, tissue injury), which arises from the
activation of peripheral nerve endings (nociceptors) that
respond to noxious stimulation [and may be described as
localized, sharp, squeezing, stabbing, or throbbing].
(2) Neuropathic pain, resulting from injury to, or dysfunction of,
the somatosensory system [burning, shooting, electric, or
tingling]. Central pain would be caused by a lesion or disease
of the central somatosensory nervous system.
(3) Visceral pain results from the activation of nociceptors of the
thoracic, pelvic, or abdominal viscera [poorly localized, dull,
crampy, or achy].
(4) Total pain: suffering that encompasses all of a child’s physical,
psychological, social, spiritual, and practical struggles134
(5) Chronic (or persistent) pain: pain beyondexpected timeof healing
A particularly vulnerable group of patients are infants and
neonates. A recent systematic review showed that neonates
admitted to intensive care units frequently suffer through an average
of 7 to 17 painful procedures per day, with the most frequent
procedures being venipuncture, heel lance, and insertion of
aperipheral venouscatheter.2 Inmost infants no analgesic strategies
are used.135 In addition, children with seriousmedical conditions are
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exposed to frequent painful diagnostic and therapeutic procedures
(eg, bone marrow aspirations, lumbar punctures, and wound
dressing changes). Furthermore, even healthy children have to
undergo significant amounts of painful medical procedures through-
out childhood: Vaccinations are the most commonly performed
needle procedure in childhood, and pain is a common reason for
vaccine hesitancy.32,90,156
Exposure to severe pain in infants without adequate pain
management has negative long-term consequences, including
increased morbidity (eg, intraventricular hemorrhage) and mor-
tality.2,152 Exposure to pain in premature infants is associated
with higher pain self-ratings during venipuncture by school age172
and poorer cognition and motor function.66 Research has also
shown that exposure to pain early in life even heightens the risk for
developing problems in adulthood (chronic pain, anxiety, and
depressive disorders), implying that adequate management of
infant and child pain is imperative.8,74,177
This Clinical Update, building on the Factsheet Pain in Children:
Management. 2019 Global Year against Pain in the Vulnerable of
the International Association for the Study of Pain [IASP],59 which
have been translated into 18 languages so far, will address the
prevention and treatment of the 3 most common pain entities in
pediatric medicine: acute pain, chronic pain, and needle pain.
2. Prevention and treatment of acute pain in children
Acute nociceptive pain might be due to tissue injury caused by
disease, trauma, surgery, interventions, and/or disease-directed
therapy. Untreated acute pain may lead to fear and even
avoidance of future medical procedures.
Multimodal analgesia (Fig. 1) is the current recommended
approach to address acute pain in hospitalized children.
Pharmacology (including basic analgesia, opioids, and adjuvant
analgesia) alonemight not be sufficient to treat childrenwith acute
pain. The addition and integration of modalities such as regional
anesthesia, rehabilitation, effective psychosocial interventions,
spirituality, and integrative (“nonpharmacological”) modalities
acts synergistically for more effective (opioid-sparing) pediatric
pain control with fewer side effects than single analgesic or
modality.55
2.1. Treat underlying disease process
Pain is foremost a symptom and might be a warning sign. After
a detailed medical history, clinical examination, and potentially
further workup (including imagery or laboratory investigations), an
underlying disease process (such as tissue injury including
infection, and trauma) needs to be addressed as appropriate in
the specific clinical scenario to avoid further harm. As an example,
in a child with increasing foot pain after orthopedic surgery, the
primary intervention would be to rule out and address a potential
compartment syndrome, and not simply to increase the analgesic
dose.
2.2. Basic analgesia
Basic (or “simple”) analgesia usually includes acetaminophen
(paracetamol) and nonsteroidal anti-inflammatory drugs
(NSAIDs). Data have shown that ibuprofen-sodium (available
over-the-counter in the United States and other countries)
compared with standard ibuprofen has a faster analgesic onset
(within 10 minutes), only requires 50% of the dose, and has
a longer duration of action.116 If NSAIDs are contraindicated due
to their side-effect profile (which includes bleeding risk and
gastrointestinal side effects), one may consider a COX-2 inhibitor
(eg, celecoxib).163 The renal toxicity profile may be somewhat
better compared with classic NSAIDs.118 For starting doses, see
Table 1. Although in some countries dipyrone (metamizole) is
commonly used as a basic analgesic, it is not available in many
countries, including the United States.
2.3. Opioids
Opioids are often indicated for medium to severe acute pain due
to tissue injury. The World Health Organization (WHO) step 2
suggests opioid use in children with persisting medium–severe
pain due to medical illness in addition to basic analgesia (and not
waiting for the effect of acetaminophen or an NSAID).180 Mor-
phine remains the “gold standard,” but other “strong” opioids,
such as fentanyl, oxycodone, hydromorphone, diamorphine (in
the United Kingdom only), and methadone are equally effective in
their respective analgesic effects. For opioid starting doses, see
Table 2; for neonates, Table 3; and for usual patient-controlled
analgesia (PCA) pump starting doses, see Table 4.
“Weak” opioids, with an analgesic ceiling effect, include codeine,
which cannot be recommended anymore due to pediatric deaths,
especially in cytochrome P450 2D6 ultrarapid metaboliz-
ers.22,24,38,47,49,88,94 Tramadol, a multimechanistic analgesic, how-
ever, seems to continue playing a key role not only in outpatient
surgery (eg, more than 6,000 pediatric tramadol scripts were filled at
Children’s Minnesota in 2018 in part due to its relative respiratory
safety profile), but also in treating episodes of inconsolability in
children with progressive neurologic, metabolic, or chromosomally
based conditions with impairment of the central nervous system.
Surprisingly, and not well based on scientific evidence, the US Food
and Drug Administration (FDA) issued a warning against pediatric
Key Points
1. According to the 2010 Declaration of Montreal, access to
pain management is a fundamental human right and it is
a human rights violation not to treat pain
2. Evidence-based pain prevention and treatment must be-
come a priority for all medical facilities providing pediatric
care
3. Effective multimodal analgesia for acute pain act syner-
gistically for more effective pediatric pain control with
fewer side effects than single analgesic or modality and
includes pharmacology (eg, basic analgesia, opioids, and
adjuvant analgesia), regional anesthesia, rehabilitation,
psychology, spirituality, and integrative (“nonpharmaco-
logical”) modalities.
4. For chronic persistent pediatric pain, an interdisciplinary
rehabilitative approach including (1) physical therapy, (2)
psychological interventions, (3) active integrative mind–
body techniques, and (4) normalizing life (eg, school,
sleep, social, and sports) has been shown most effective.
5. Opioids are usually not indicated in chronic pain in the
absence of new tissue injury.
6. For elective needle procedures, evidence now mandates
to consistently offer 4 strategies to every child every time:
(1) topical anesthetics, (2) sucrose or breastfeeding for
infants 0 to 12 months, (3) comfort positioning (including
swaddling, skin-to-skin contact, or facilitated tucking for
infants, sitting upright for children), and (4) age-
appropriate distraction.
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use of tramadol and cited the data of 3 children who have died
worldwide in the previous 49 years, therefore actually making it far
safer than any other opioid. Unfortunately, this warning may place
children at greater risk for unrelieved pain and other distressing
symptoms by encouraging clinicians to either use strong opioids in
the outpatient setting with a higher risk of respiratory depression or
not use opioids at all.54
“By the clock”: when pain is constantly present, both adminis-
tration of basic analgesia and opioid should usually be scheduled
“around the clock” (eg, acetaminophen every 6 hours scheduled
and/ormorphine every 4hours scheduled). As-neededprescriptions
only (without scheduled analgesia) often do not reach the patient,
and “PRN” (“pro re nata” or “as-needed”) is often translated into
“patient receives nothing”, with 69 percent of hospitalized pediatric
patients for whom analgesics had been ordered “PRN” did not
receive a single dose in one study.79
2.4. Adjuvant analgesia
Adjuvant analgesics may improve pain control either in addition to
basic analgesia and/or opioids, or they may also act as primary
analgesics, especially in neuropathic and visceral pain treatment.41,45
Figure 1. Pediatric Multimodal Analgesia: Implementing some or, depending on the clinical scenario, all modalities in the treatment of acute pain acts
synergistically for more effective (opioid-sparing) pediatric pain control with fewer side effects than single analgesic or modality.
Table 1
Basic analgesia for children.
Drug Route Age Pediatric dose Maximal dose Dosing interval
Ibuprofen PO .3–6 months* 5–10 mg/kg 400–600 mg/dose 6–8 hours
Ibuprofen-sodium† 256-mg tablet 5 200-mg
ibuprofen
PO .6 months 5–(10) mg/kg 200–(400) mg/dose 6–8 hours
Acetaminophen (paracetamol) PO, PR Neonates 0–30 days 5–10 mg/kg 20–40 mg/kg/day 4–6 hours (maximum 4 doses/day)
PO, PR Infants 1–3 months 10 mg/kg 40 mg/kg/day 4–6 hours (maximum 4 doses/day)
PO, PR 4 months—2 years 10–15 mg/kg 40–60 mg/kg/day 4–6 hours (maximum 4 doses/day)
PO, PR .2 years 10–15 mg/kg 90 mg/kg/day or 650 mg Q6h 4–6 hours
IV‡ ,1 year ,10 kg5 7.5 mg/kg 30 mg/kg/day 6 hours
IV‡ 1–2 years 15 mg/kg 60 mg/kg/day 6 hours
IV‡ .2 years (,50 kg) 15 mg/kg 75 mg/kg/day 6 hours
IV‡ .13 years (.50 kg) 1000 mg 4000 mg/day 6 hours
Ketorolac§ IV 6 months–2 years* 0.25 mg/kg 30 mg/dose 6–8 hours
IV .2 years 0.5 mg/kg 30 mg/dose 6–8 hours
Celecoxib║ PO .6 months 1–2 mg/kg 100 mg/dose 12–24 hours
* For NSAIDs in infants ,3 to 6 months, consult Pediatric Pain Service.
† Fast-acting, compared with standard ibuprofen: onset of analgesia after 10 minutes, last longer, and only half the dose required.
‡ Due to high cost, only if rectal or oral administration contraindicated, re-evaluate daily.
§ Recommend dosing no longer than 5 days
║ If classical NSAIDs contraindicated, safety and efficacy have been established in children 2 years of age or older for a maximum of 6 months of treatment in JRA.
NSAIDs, nonsteroidal anti-inflammatory drugs.
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This heterogenic group includes gabapentinoids33,68 (such as
gabapentin and pregabalin), alpha-2-adrenergic agonists10,23,78
(such as clonidine or dexmedetomidine), low-dose tricyclic anti-
depressants (such as amitriptyline or nortriptyline), N-methyl-D-
aspartate (NMDA) channel blockers (such as low-dose ket-
amine40,86), and sodium-channel blockers (such as lido-
caine39,109,127,139,178). See Table 5 for dosing recommendations.
Cannabis and medical marijuana (including cannabidiol [CBD]
and tetrahydrocannabinol [THC]) lack any evidence to support its
use for treatment of acute or chronic pain.29,76 The updated
American Academy of Pediatrics policy opposes marijuana
use,126 citing lack of research and potential harms including
correlationwithmental illness,19 testicular cancer,28,97,167 decline
in IQ,113,115 and increased risk of addiction.114 In our clinical
practice, we do not support the use of marijuana (or medical
cannabis) for a child with a primary pain disorder and a normal life
expectancy. However, in children with life-limiting conditions, the
administration of medical cannabis might be requested by
patients and their parents and certainly may be considered on
a case-by-case basis. It is important to watch carefully for side
effects (including pancreatitis and psychosis).
2.5. Integrative medicine
Many integrative medicine (other terms used may include “non-
pharmacologic,” “complementary,” or “alternative medicine”)
Table 2
Opioid analgesics: usual starting doses for children with acute pain (>6 months).*,†
Medication (route of administration) Starting dose IV IV:PO ratio Starting dose PO (or transdermal)
Morphine (PO, SL, IV, SC, and PR)‡ Bolus dose: 0.05–0.1 mg/kg (max. 5 mg)
every 2–4 hours
1:3 (ie, 1 mg IV 5 3 mg PO) 0.15–0.3 mg/kg (max. 7.5—15 mg) every
4 hours
Continuous infusion: 0.01–0.02 mg/kg/h
(max. 0.5–1 mg/h)
Fentanyl (IV, SC, SL, transdermal, and
buccal)
Bolus dose: 0.5–1 mcg/kg (max. 25–50
mcg) (slowly over 3–5 minutes—fast bolus
of high doses, especially .5–10 mcg/kg
may cause thorax rigidity)
1:1 (IV to transdermal) 12 mcg/h patch (must be on the equivalent
of at least 30-mg oral morphine/24 hours,
before switching to patch)
Continuous infusion: 0.5–1mcg/kg/h (max.
25–50 mcg/h)
Hydromorphone (PO, SL, IV, SC, and
PR)‡
Bolus dose: 15–20 mcg/kg (max. 1 mg)
every 4 hours
1:5 (ie, 1 mg IV 5 5 mg PO) 60 mcg/kg (max. 2000–3000 mcg or 2–3
mg) every 3–4 hours
Continuous infusion: 2–5 mcg/kg/h (max.
100–250 mcg/h)
Oxycodone (PO, SL, and PR)‡ IV not available in the United States (Bolus
dose: 0.05–0.1 mg/kg [max 2.5–5 mg]
every 4 hours)
1:2 (ie, 1 mg IV5 2 mg PO) IV not available
in the United States
0.1–0.2 mg/kg (max. 5–10 mg) every 4
hours or 0.15–0.3 mg/kg (max. 7.5–15
mg) every 6 hours
Tramadol (PO and PR) IV not available in the United States (Bolus
dose: 1 mg/kg every 3–4 hours)
1:1 1–2 mg/kg every 3–4 hours, max. Of 8 mg/
kg/day (.50 kg: max. of 400 mg/day)
Continuous infusion: 0.25 mg/kg/h
Methadone (PO, PR, SL, and IV)§ 0.04–0.08-mg/kg (max. 2–4 mg) IV Q8h 1:1–1:2 (in adults usually IV usually 50% of
PO dose, in pediatrics consider IV5 80% of
PO dose)
0.05–0.1-mg/kg (max. 2.2–5 mg) PO Q8h
*Above doses represent starting doses, which then need to be titrated to effect and may be significantly higher.
†Maximum per kg dose capped at 50-kg body weight.
‡Calculated rescue (breakthrough) dose: 10% to 16% of 24-hour opioid dose to be given every 2 hours as needed. (Depending on the clinical scenario a breakthrough dose may given every 1-4 hours as needed.) Inform
prescribing clinician, if requiring more than 3 breakthrough doses in less than 24 hours.
§Methadone should not be prescribed without proper training about dosing and potential side effects. Prescribing clinicians should closely observe the child for potential side effects from the time he or she receives the first
dosed and following medication changes such as tapering, titration, or adding other potentially sedating medications.
IV, intravenous; n/a, not applicable; PO, by mouth; PR, rectal; SL, sublingual; SC, subcutaneous.
Table 3
Opioid analgesia for neonates and infants 0–6 months of age.*
Opioids
Morphine PO/PR/SL 0.075–0.15 mg (neonates 0–30 days) 6 hours
0.08–0.2 mg (infants 1–6 months) 4–6 hours
Morphine† IV/SC‡ 0.025–0.05 mg/kg (neonates 0–30 days) 6 hours
0.1 mg/kg (infants 1–6 months) 6 hours
Infusion (with PCA bolus of same dose):
0.005–0.01 mg/kg/h (neonates 0–30 days)
0.01–0.03 mg/kg/h (infants 1–6 months)
Fentanyl† IV/SC‡ 1–2 mcg/kg (neonates and infants 0–12 months) 2–4 hours
Infusion (with PCA bolus of same dose):
0.5–1 mcg/kg/h (neonates and infants 0–6
months)
Oxycodone PO/PR/SL 0.05–0.125 mg/kg (infants 1–6 months) 4 hours
* World_Health_Organization. WHO—Principles of Acute Pain Management for Children http://whqlibdoc.who.int/publications/2012/9789241548120_Guidelines.pdf. 2012.
† The intravenous doses for neonates are based on acute pain management and sedation dosing information. Lower doses are required for nonventilated neonates.
‡ Administer IV slowly over at least 5 minutes.
PCA, patient-controlled analgesia.
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modalities seem very effective in treating and preventing pediatric
acute pain. In infants, these modalities include breastfeeding, non-
nutritive sucking with sucrose 24%, and skin-to-skin con-
tact.21,56,141,149 In toddlers, school children’s and young adults’
age-appropriate effective integrative modalities include distraction,
deep breathing, biofeedback, self-hypnosis, yoga, acupuncture,
transcutaneous electrical nerve stimulation and
massage.12,35–37,44,46,81,96,133,171,173,175,181 Many active mind-
body techniques, such as guided imagery, hypnosis, biofeedback,
yoga, and distraction may result in pain reduction through
involvement of several mechanisms simultaneously within the
analgesic neuraxis.3,36,93,95,151
2.6. Psychological interventions
Anxiety, depression, catastrophizing thoughts about pain, and
behavioral disorders represent risk factors for the evolvement of
acute to chronic pain in children and adolescents.103,164 A recent
meta-analysis of clinical trials involving adolescents and adults
undergoing orthopedic surgery166 demonstrated that preopera-
tive psychological interventions, such as cognitive-behavioral
therapy (CBT), hypnosis, relaxation, emotional counselling, and
mixed psychotherapies, are effective to reduce acute post-
operative anxiety and to improve longer term quality of life, with no
effects found on postoperative pain.
2.7. Physical therapy, exercise, and rehabilitation
Physical therapy and exercise are key modalities in the treatment
of children with acute and other pain conditions, including
pediatric patients with serious illness.30,101,105,108,110,119,120,143
Independent from pain treatment, increasing physical activity
levels has also shown to decrease levels of depression.84 Graded
Motor Imagery, includingmirror therapy, is the process of thinking
about moving without actually moving and has been shown
especially effective in children when moving the injured body part
is too painful.131
2.8. Spirituality
A correlation between spiritual coping and the quality of life in
pediatric patients with chronic illness has been described.65,132
Table 4
Usual starting doses for patient (or nurse)-controlled analgesia (PCA) pumps for children in acute pain (>6 months).
Continuous infusion (mcg/kg/h) PCA bolus (mcg) Lock-out time (minutes) Maximum number of boluses/hour
Morphine 10–20 (max. 500–1000) 10–20 (max. 500–1000) 5–10 4–6
Hydromorphone 2–5 (max. 100–250) 2–5 (max. 100–250) 5–10 4–6
Fentanyl 0.5–1 (max. 25–50) 0.5–1 (max. 25–50) 5 4–6
Dose escalation usually in 50% increments both for continuous and PCA bolus dose (Department of Pain Medicine, Palliative Care & Integrative Medicine, Children’s Hospitals and Clinics of Minnesota, USA). Doses for children
.6 months of age and are capped at 50-kg body weight.
Table 5
Adjuvant analgesics used in pediatric pain management.*
Class Medication Dose Route of
administration
Comments/side effects (see text for
further details)
Tricyclic antidepressants (TCA) Amitriptyline Starting dose 0.1 mg/kg QHS, usually slowly
titrated up to 0.5 mg/kg (max. 20–25 mg)
PO Tertiary amine TCA; stronger anticholinergic
side effects (including sedation) than
nortriptyline
Nortriptyline Starting dose 0.1 mg/kg QHS, usually titrated
up to 0.5 mg/kg (max. 20–25 mg)
PO Secondary amine TCA; anticholinergic side
effects
Gabapentinoids Gabapentin Starting dose 2 mg/kg QHS, usually slowly
titrated up to initial target dose of 6 mg/kg/
dose TID (max. 300 mg/dose TID). Max. dose
escalation to 24 mg/kg/dose TID (max. 1200
mg/dose TID)
PO Slow dose increase required; side effects:
Ataxia, nystagmus, myalgia, hallucination,
dizziness, somnolence, aggressive
behaviors, hyperactivity, thought disorder,
and peripheral edema
Infants ,1 year; 4.5 mg/kg/dose Q6h,
titrated to max. 18 mg/kg/dose Q6h
Pregabalin Starting dose 0.3 mg/kg QHS, usually slowly
titrated up to initial target dose of 1.5 mg/kg/
dose BID (max. 75 mg/dose BID). Max. dose
escalation to 6 mg/kg/dose BID (max. 300
mg/dose BID)
PO Switch from gabapentin, if distressing side
effects or inadequate analgesia. Side effects:
Ataxia, nystagmus, myalgia, hallucination,
dizziness, somnolence, aggressive
behaviors, hyperactivity, thought disorder,




Lidocaine 5% Max. of 4 patches (in patients .50 kg) 12
hours on/12 hours off
Transdermal patch Not for severe hepatic dysfunction
Alpha agonist Clonidine 1–3 mcg/kg (max 150 mcg) QHS to Q6h PO/transdermal
Dexmedetomidine Infusion: 0.3 mcg/kg/h; titrate to max. 2 mcg/
kg/h
IV
Hormone Melatonin 0.06–0.2 mg/kg (max. 3–10 mg) QHS PO For sleep induction; use extended-release, if
interrupted sleep, possible analgesic effect
* Friedrichsdorf SJ. Prevention and treatment of pain in hospitalized infants, children, and teenagers: from myths and morphine to multimodal analgesia. In: Pain 2016: Refresher Courses. 16th World Congress on Pain.
Washington, DC: International Association for the Study of Pain, IASP Press; 2016:309–319.
BID, bis in die, twice a day; IV, intravenous administration; PO, per os, oral administration; Q6h, every 6 hours; QHS, every night at bedtime; TID, ter in die, 3 times a day.
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Parents of children with serious illness described religion,
spirituality, and/or life philosophy playing an important role in
their life and of the affected child.75 Most children’s hospitals
encourage the inclusion of spiritual aspects of life into health care,
for instance, by making hospital chaplains available.
2.9. Regional anesthesia
One of the most effective analgesic modalities in children with
tissue injury represents regional or neuraxial anesthe-
sia.13,26,27,73,140,142 Nociceptive pathways may be blocked using
central neuraxial infusions, peripheral nerve, and plexus blocks or
infusions, or neurolytic blocks.136 Benefits of regional anesthesia
include reduced (or no) need for opioid analgesics, absence of
systemic side effects such as sedation or nausea, improved
gastrointestinal motility, reduced incidence of delirium, and the
opportunity for the patient to be awake and able to remember
conversations with clinicians and family.11 In addition to motor
weakness, less common potential side effects with epidural
include pruritus, urinary retention, and hypotension.
3. Management of chronic pediatric pain
Pediatric chronic pain is a significant problem with conservative
estimates that posit 20% to 35% of children and adolescents
affected by it worldwide.58,91,147 Pain experienced by patients in
children’s hospitals is known to be common, with more than 10%
of hospitalized children showing features of chronic
pain.48,148,162,182 Although the majority of children reporting
chronic pain are not greatly disabled by it,80,176 about 3% of
pediatric chronic pain patients require intensive rehabilitation.71
The 2012 American Pain Society Position Statement, “As-
sessment and Management of Children with Chronic Pain,”
indicates that chronic pain in children is the result of a dynamic
integration of biological processes, psychological factors, and
sociocultural variables, considered within a developmental tra-
jectory.43 Unlike in adult medicine, chronic pain in children is not
necessarily defined by using arbitrary temporal parameters (eg, 3
months) but rather uses a more functional definition such as
“pain that extends beyond the expected period of healing” and
“hence lacks the acute warning function of physiological
nociception.”168,169
3.1. Interdisciplinary management of chronic pediatric pain
An interdisciplinary approach combining (1) rehabilitation, (2)
integrative medicine/active mind–body techniques, (3) psychol-
ogy interventions, and (4) normalizing daily school attendance,
sports, social life, and sleep seem to bemost effective. As a result
of restored function, pain improves and commonly resolves.
Opioids are not indicated for primary pain disorders (including
centrally mediated abdominal pain syndrome, primary head-
aches [tension headaches/migraines], and widespread muscu-
loskeletal pain) and other medications, with few exceptions, are
usually not first-line therapy.
A recent Cochrane review concluded that face-to-face
psychological treatments might be effective in reducing pain
outcomes for children and adolescents with headache and other
types of chronic pain.42 Psychological treatments have also been
found to be effective for reducing pain-related disability in children
and adolescents with mixed chronic pain conditions at post-
treatment and follow-up and for children with headache at follow-
up.31 The most commonly used psychological therapy,
CBT,31,121 has been shown to reduce pain severity in children
and adolescents with widespread musculoskeletal/joint pain,
headaches, abdominal pain, and headaches.31,121
As proposed by Palermo’s conceptual framework for un-
derstanding chronic pain in children and adolescents122,124 and
the Interpersonal Fear-Avoidance Model,60,62 a child’s social
environment and especially parents play a key role in un-
derstanding childhood chronic pain. Increasing evidence sug-
gests that it is important to target parental catastrophizing
thoughts, parental distress, and parental behaviors with regard to
child pain (eg, protective behaviors), which has led to recom-
mendations to incorporate parents within the multidisciplinary
treatment.62 A recent Cochrane review100 indeed indicated
a beneficial effect of psychological therapies for parents of
children with chronic pain conditions on parenting behavior (eg,
reduction of protective behaviors) at post-treatment and follow-
up. Furthermore, this review also showed that psychological
therapies can improve parent mental health in this population.
When considering children’s treatment outcomes, a small
beneficial effect was found on children’s behavior and disability
at post-treatment and follow-up. Furthermore, a moderate
beneficial effect was found on children’s pain at post-treatment,
but no effects on child mental health at post-treatment or
follow-up.
With regard to the specific effects of CBT, the available
evidence shows that CBT is effective in decreasing parents’
protective responses in children with chronic (or persistent)
abdominal pain.102 Furthermore, a recent randomized controlled
trial examining the effects of family-based CBT delivered through
the internet99,123 demonstrated greater reductions in activity
limitations from baseline to 6-month follow-up for internet-
delivered CBT compared with an educational intervention.
Additional beneficial effects of CBT were found on sleep quality,
reduction of parents’ protective behaviors, and treatment
satisfaction.123 Secondary longitudinal analyses further showed
that child disability, parent protective behavior, and parent
distress improved over the 12-month study period.99 Indeed,
a recent systematic review on the effects of internet-delivered
CBT in youth with chronic pain and their parents161 showed that,
compared with pretreatment, internet-delivered CBT had me-
dium to large benefits on child pain intensity, activity limitations,
and parental protective behaviors immediately after treatment.
Furthermore, small to medium positive effects were found for
child depressive symptoms, anxiety, and sleep quality. However,
still limited evidence is available, and more trials are needed
(Box 1).161
3.2. Early screening of children’s risk profile to tailor
clinical care
To ensure optimal clinical care and treatment for children and
adolescents who present with chronic pain complaints at the
hospital, early identification of risk factors for adverse outcomes
may be warranted. Recently, a 9-item Pediatric Pain Screening
Tool (PPST)70,145 has been developed, to rapidly assess risk
factors associated with adverse outcomes, such as sleep
problems, catastrophizing thoughts, pain-related fear, and
depression. Early identification of risk factors that may maintain
chronic pain allows optimal stratified care and may improve
recovery rates. Importantly, evidence supports the generalizabil-
ity of the PPST across pain complaints.70,145 Based on this brief
scale, a risk profile of the child can be calculated, which provides
indications for the type of care needed, ie, conservative treatment
including education/advice, for instance, regarding sleep hygiene
(low-risk profile), referral to physiotherapy (medium-risk profile), or
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referral for multidisciplinary treatment, for instance, including
psychological treatment and physical therapy for elevated pain-
related fear (high-risk profile).70,145
Given the major role of parents in influencing a child’s pain
experience and functioning,60,62 Simons et al. also developed
a brief 12-item self-report screening tool (Parent Risk and Impact
Screening Measure [PRISM]146) to assess parents’ psychosocial
functioning (ie, parents’ distress and health), behavioral
responses to their child’s pain, and the impact of the child’s pain
on the family. Similar to the PPST, risk profiles of parents can be
calculated, identifying parents at low, medium, or high risk and
informing the clinician, which parents would benefit from a referral
for parent-focused treatment or targeted pain-related interven-
tions for parents (eg, to reduce protective behaviors).
3.3. Strengthening resilience mechanisms
Next to identifying and targeting risk factors for adverse
outcomes, it has increasingly been acknowledged that it is also
important to identify and promote factors or strengths that can
improve adaptive or resilient functioning.25,61 Resilient function-
ing can be best defined as the ability to restore and sustain living
a fulfilling life in the presence of pain61 (eg, is the child able to
engage in activities he/she finds important despite the pain; can
he/she keep high levels of well-being despite the pain). When
a child presents with pain complaints at the hospital, attention
should not only be paid to malfunctioning but also to what goes
well in the child’s life, and how this resilient functioning can be
further improved. This can be performed by strengthening
resilience mechanisms such as positive affect, psychological
flexibility, acceptance of pain, gratitude, and availability of family
support over and above targeting/reducing risk factors such as
pain-related fear.61 Although empirical evidence is still in its
infancy, studies in adults show promising results of resilience-
based treatment approaches such as positive psychology
interventions128 and acceptance-based approaches.174 Al-
though more empirical research is needed which interventions
are most effective for whom, interventions promoting resilience
mechanisms may be particularly valuable in early stages of
treatment, to support adaptive domains of functioning and to
prevent adverse outcomes in the long run. In children with high-
risk profiles, it may be an important component of a multimodal
approach to treatment.
Research on Acceptance and Commitment Therapy
(ACT),69,129 a third generation behavior therapy that aims to
promote resilient functioning by fostering psychological flexibility
and acceptance of pain, is growing, and there is accumulating
evidence that it can promote better functioning in adolescents
with chronic pain, better pain acceptance, better school
attendance, and reduced catastrophizing and anxiety and
reduced use of health care facilities.57,129 Furthermore, a recent
nonrandomized clinical trial in adolescents with chronic pain and
their parents89 showed that acceptance and commitment
therapy had positive effects not only on adolescents’ functioning
but also on parents. Specifically, it was found to lead to significant
improvements in parents’ depressive symptoms and psycholog-
ical flexibility. Moreover, this study showed that improvements in
parents’ psychological flexibility were associated with better
adolescent pain acceptance over time.
4. Management of needle pain in children
Untreated needle pain, caused by procedures such as vacci-
nations, blood draws, injections, and venous cannulation can
have long-term consequences including needle phobia, prepro-
cedural anxiety, hyperalgesia, and avoidance of health care,
resulting in increased morbidity and mortality.153,154 Current
evidence,154,158,159 supported by guidelines from the Canadian
Paediatric Society,18,82 HELPinKids,72,111,112,157 and recently
brought forward by science-to-social media campaigns (“Be
Sweet to Baby”21 and especially “It Doesn’t Have to Hurt” by
Chambers et al.20), strongly suggests that 4 bundled modalities
Box 1. Treatment of chronic pain and primary pain
disorders.50
(1) Rehabilitation (eg, physical therapy, graded motor imagery,131 and
occupational therapy)
(2) Integrative (“nonpharmacological”) modalities (eg, mind–body tech-
niques such as diaphragmatic breathing, bubble blowing, self-
hypnosis, progressive muscle relaxation, and biofeedback plus
modalities such as massage, aromatherapy, acupressure, and
acupuncture)
(4) Psychology (eg, cognitive-behavioral therapy, acceptance and
commitment therapy)
(4) Normalizing life (usually life gets back to normal first, then pain goes
down—not the other way around) Sports/exercise Sleep hygiene Social life School attendance
(5) Medications (may or may not be required) Basic analgesia (eg, paracetamol/acetaminophen, NSAIDs,
and COX-2 inhibitor) Adjuvant analgesics (eg, gabapentin, clonidine, and/or
amitriptyline) Of note: Opioids in the absence of new tissue injury, eg,
epidermolysis bullosa and osteogenesis imperfecta, are
usually not indicated
Box 2. Prevention and treatment of needle pain.
Offer a bundle of these 4 (or 3 for.12 months) evidence-based modalities
to all children all the time:
(1) Topical anesthesia “Numb the skin” eg, 4% lidocaine cream
(administered 30 minutes prior procedure), EMLA (lidocaine 2.5%
and prilocaine 2.5%) cream (60 minutes prior), amethocaine
[tetracaine] 4% gel (30–60 minutes prior) or needleless lidocaine
application using pressurized gas to propel medication through the
skin (1 minutes prior) eg J-Tip®
(2) Sucrose or breastfeeding for infants 0 to 12 months.
(3) Comfort positioning “Do not hold children down.” For infants,
consider parent-infant skin-to-skin (kangaroo care) contact. If not
feasible, consider swaddling, warmth, facilitated tucking, and/or
cobedding for twins. For children 6 months and older, offer sitting
upright with parents holding them on their lap or sitting nearby.
(4) Age-appropriate distraction,9,137,171 such as toys, books, blowing
bubbles or pinwheels, stress balls, and using apps, videos, or games
on electronic devices.
Of note: If above ineffective or not feasible, consider nitrous gas analgesia/
sedation. For needle phobia, in addition, consider referral to pediatric
psychologist.
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should be offered for elective needle procedures to reduce or
eliminate pain and anxiety experienced by children (Box 2).52
Failure to prevent or minimize treatable procedural pain in
children is now considered both inappropriate and unethical.51
(1) Topical anesthesia needs to be offered (and unless verbal
children decline for themselves), administered to all children
36 weeks’ corrected gestational age and older for every
elective needle procedure. Topical anesthetics include 4%
liposomal lidocaine cream160 (of note, currently, all 4%
lidocaine cream available over-the-counter in the United
States and Canada is liposomal), EMLA (lidocaine 2.5% and
prilocaine 2.5%) cream, or needle-less lidocaine application
through a J-tip (sterile, single-use, disposable injector that
uses pressurized gas to propel medication through the
skin).106,107
EMLA creammay be on the skin for up to 4 hours and provides
maximum analgesia after at least 60 minutes compared with 4%
lidocaine cream, which is already effective after 30 minutes and
may be on skin up to 2 hours.34,92 In comparison with EMLA
cream, amethocaine (tetracaine) 4% gel is superior in preventing
pain associated with needle procedures.98
Only topical anesthesia, such as lidocaine provided consistent
analgesia within an additive pain intervention regimen during
vaccinations in infants.160 Dispelling a common myth, topical
anesthetics do not constrict veins and do not decrease the
chance of venous cannulation.52,106,138 Not surprisingly, topical
anesthesia even works for kids under general anesthesia and
should therefore be considered.67
Other modalities, including vapocoolants, ice, cool/cold
packs, and vibrating devices might be helpful but currently have
insufficient evidence for or against their use to reduce pain at time
of injection and therefore should be considered in addition to
topical anesthetics, but not instead of numbing cream.155
(2) For term infants 0 to 12 months,21 breastfeeding is effective in
preventing or decreasing procedural pain in infants and
equally effective to sucrose.141 Sucrose reduces pain and
cry during painful procedures, such as venipunctures, and
seems to facilitate the release of endogenous opioids, as the
mu-opioid antagonist naloxone blunts the effect.56,149 The
minimally effective dose of 24% sucrose for procedural pain
relief in neonates in a recent randomized controlled trial (RCT)
has been determined as “just a drop” (0.1mL)150 and therefore
can be administered to infants who are “NPO” (nothing by
mouth). It should be administered about 2 minutes before
the painful procedure and may be repeated during the
intervention.
(3) Comfort positioning: For elective needle procedures, children
should not be held down (this might be different in a life-saving
intervention). For infants, consider primarily skin-to-skin (kanga-
roo care) contact. If not feasible, consider swaddling, warmth,
facilitated tucking, and/or cobedding for twins.4,14–17,63,64,85 For
children 6 months and older, offer sitting upright with parents
holding them on their laps or sitting nearby.
Restraining children for procedures is never supportive,
creates a negative experience, and increases their anxiety and
pain. In fact, children with cancer who have been restrained for
procedures report that it makes them feel ashamed, humiliated,
powerless, and they report having lost their right to control their
own body.87
Of note, a just-published RCT with 242 stable preterm infants
by Campbell-Yeo et al.17 seems not only to suggest that
maternal-infant skin-to-skin contact, or kangaroo care (KC) is
equally effective as 24% oral sucrose, but that the combination of
maternal KC and sucrose did not seem to provide additional
benefit. Further research on this topic would be required, and as
the result of this, future RCTs may challenge current recom-
mendations. The current recommendation of using sucrose as
a standard of care will remain in place for the time being.
(4) Age-appropriate distraction includes the use of toys, books,
blowing bubbles or pinwheels, stress balls, and using apps,
videos, or games on electronic devices.9,137,171 A recent
Cochrane review identified sufficient evidence for the effec-
tiveness of cognitive-behavioral therapy, breathing interven-
tions, distraction, and hypnosis for reducing children’s pain
and/or fear due to needles.7
Offering these 4 simple modalities (or 3 to children older than
12 months) and not just some of them for all needle procedures
for all children all the time has now be implemented systemwide in
children’s hospitals and pediatricians’ offices on several
continents.52,130
In addition to these 4modalities, it is recommended that health
care professionals and parents use neutral words and avoid
language that can increase fear andmay be falsely reassuring (eg,
“it will be over soon”; “you will be ok”).153
(5) Deferral process (or “plan B”): If adequate procedural
analgesia and anxiolysis is not feasible with the above bundled
modalities alone (eg, because the child has been held down in
the past and has become too anxious, and/or it was difficult to
draw blood in the past, etc.) consider involving a child-life
specialist, referral to a child-psychologist to offer CBT to
overcome needle phobia and/or consider nitrous gas.53
4.1. Nitrous gas analgesia and sedation
Data reveal that children receiving nitrous gas before and during
painful procedures have lower levels of distress, lower pain
scores, were more relaxed, and many have no recollection of the
procedure afterwards.77,125,165 Nitrous gas concentrations be-
tween 40% and 70% can be titrated to achieve minimal sedation
only, avoiding moderate sedation.104,183 Children receiving
minimal sedation are able to respond to verbal commands,
maintain, and protect their airway, spontaneous ventilation, and
cardiovascular functions are unaffected.1
5. Conclusion
Access to pain management is a fundamental human right, and it
is a human rights violation not to treat pain.83 Yet, pain prevention
and treatment in pediatric patients compared with adult medicine
is often not only inadequate, but also even less often implemented
the younger pediatric patients are. Effective multimodal analgesia
for acute pain includes pharmacology, regional anesthesia,
rehabilitation, psychology, spirituality and integrative (“nonphar-
macological”) modalities, which act synergistically for more
effective pediatric pain control with fewer side effects than single
analgesic or modality. For chronic pediatric pain, including
primary headaches (migraines/tension headaches), centrally
mediated abdominal pain, andwidespreadmusculoskeletal pain,
an interdisciplinary rehabilitative approach including physical
therapy, psychological approaches (eg, CBT, ACT), integrative
active mind-body techniques, and normalizing life (school, sleep,
social, sports) has been shownmost effective. Opioids are usually
not indicated in chronic pain in the absence of new tissue injury.
For elective needle procedures, such as blood draws, intrave-
nous access, injections, or vaccination, overwhelming evidence
now mandates that a bundle of 4 modalities to eliminate or
decrease painmust be offered to every child every time: (1) topical
anesthesia, eg, lidocaine 4% cream; (2) comfort positioning, eg,
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skin-to-skin contact for infants or not restraining children; (3)
sucrose or breastfeeding for infants; and (4) age-appropriate
distraction. A deferral process for children where this bundle is
ineffective may include nitrous gas analgesia and sedation.
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